Singapore HSA registration DE0506960
Abbott Diagnostics Korea Bioline™ HIV 1/2 3.0
Device classification
- Device Class
- CLASS D IVD
- Medical Speciality Area
- Microbiology
Registration information
- Registration Number
- DE0506960
- Registration Date
- June 15, 2022
- Retention Due Date
- June 14, 2025
Product description
The Bioline™ HIV 1/2 3.0 is a rapid, qualitative test for the detection of antibodies to all isotypes(IgG, IgM, IgA) specific to HIV-1 including subtypes-O and HIV-2 simultaneously in human serum, plasma or whole blood. The Bioline™ HIV 1/2 3.0 is intended only for professional use, only for an initial screening test and reactive samples should be confirmed by a supplemental assay such as ELISA or Western Blot test.
Product Owner
- Short Name
- Abbott Diagnostics Korea Inc.
- Address
- 65, Borahagal-ro, Giheung-gu,, Yongin-si, Gyeonggi-do 17099, KOREA, REPUBLIC OF
Registrant
- Address
- 3 FRASER STREET, DUO TOWER, #23-28, SINGAPORE 189352
Importer
- Address
- 10 RAEBURN PARK, #01-33, SINGAPORE 088702
Model information
- Model Name(s)
- Bioline HIV 1/2 3.0 Bioline HIV 1/2 3.0 Bioline HIV 1/2 3.0
- Model Identifier(s)
- 03FK10 03FK11 03FK16
About this record
Access comprehensive regulatory information for Abbott Diagnostics Korea Bioline™ HIV 1/2 3.0 in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0506960 and owned by Abbott Diagnostics Korea Inc.. The device was registered on June 15, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS D IVD